| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,201 | 9,123 | 9,241 | 9,067 | | Cost of Revenue | 1,097 | 1,036 | 1,152 | 1,716 | | | Gross Profit | 8,104 | 8,087 | 8,088 | 7,351 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,083 | 998 | 1,251 | 552 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,427 | 1,420 | 1,394 | 1,376 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,594 | 5,668 | 5,443 | 5,423 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 158 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,327 | 5,094 | 5,443 | 5,126 | | Interest Expense | 1,146 | 1,161 | 1,126 | 1,303 | | Income Before Tax | 5,181 | 3,933 | 4,317 | 3,823 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (189) | (268) | (306) | (297) | | | | Net Income From Continuing Ops | 4,417 | 4,240 | 4,011 | 3,823 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,417 | 4,240 | 4,011 | 3,823 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,417 | $4,240 | $4,011 | $3,823 |
|
0.51% Nasdaq 
Income Statement
